NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Guideline title The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care (update), including the management of women and men diagnosed with breast cancer who also have a history of familial breast cancer 1.1 Short title The remit The NCC-C has been com
- A |
J |K |
U |V |
Association of racing commissioners international, incGreyhound Medication Classification and Penalty Guidelines
This document is intended to assist the racing judges at Texas pari-mutuel
greyhound racetracks in issuing consistent and effective rulings against licensees for
violations of the Texas Racing Act (Act) and the Texas Racing Commission's rules
(Rules) prohibiting the illegal influencing of a race. It is the policy of the Commission
to discipline licensees in a consistent and fair manner that will foster honest and safe
pari-mutuel racing and a better understanding of the Commission's rules.
Under the Act, §3.16, the Commission is charged with adopting rules prohibiting a
person from illegally influencing the outcome of a race, including rules relating to the
use of a prohibited substance. The Commission is authorized by the Act to conduct
pre-race and post-race testing to determine whether a prohibited substance was
present in a race animal. The Act further provides:
(1) considered by law to be the absolute ensurer that no prohibited substance has been administered to the animal; and (2) is responsible for ensuring that no prohibited substance is (Act, §3.16(h)) In Rule, §311.104(b), the Commission adopts the "absolute insurer" rule, which is in practice in most U.S. racing jurisdictions. This rule states that each trainer shall ensure that a race animal that runs a race while in the care and custody of the trainer is free from all prohibited drugs, chemicals, or other substances. Rule, §319.1(b) defines a prohibited drug, chemical, or other substance as: (1) any stimulants, depressants, tranquilizers, local anesthetics, drugs, [or] other drug metabolites which could affect the health or performance of a race animal, however minimal, except as expressly permitted by this chapter; (2) a drug permitted by this chapter in excess of the maximum or other restrictions in this chapter; and (3) [a] drug or substance, regardless of how harmless or innocuous it might be, which interferes with the detection of stimulants, depressants, tranquilizers, local anesthetics, drugs, or drug metabolites which could affect the health or performance of a race animal, however minimal, or quantitation of drugs permitted by this chapter. (Rules, §319.1(b)) This policy is developed and adopted pursuant to Rule §319.304(b), which authorizes the Executive Secretary to promulgate a classification for prohibited Greyhound Medication Classification and Penalty Guidelines drugs, chemicals, and other substances and a recommended schedule for
Responsibility for Violation
Because the Act and the Rules require a trainer to prevent the administration of
prohibited substances to a race animal, it is the Commission's policy to hold the
trainer of record for a race animal responsible when a pre-race or post-race
specimen from the animal tests positive for a prohibited drug, chemical, or other
The classification of substances is based largely on the Uniform Classification
Guidelines for Foreign Substances issued by the Association of Racing
Commissioners International. The classification of a given substance is based on
several factors, including the substance's pharmacology, its ability to influence the
outcome of a race, whether or not it has a legitimate therapeutic use in a race horse,
or other evidence that it may be used improperly.
Pharmacology. Substances that are known to be potent stimulants or depressants are placed in higher classes, while those that have or would be expected to have little effect on the outcome of a race are placed in lower classes. Use Patterns. Consideration is given to placement of substances based on practical experience with their use and the nature of positive tests. For example, procaine positives have in the past been associated primarily with the administration of procaine penicillin, and this has been taken into consideration in the placement of procaine into Class 6 instead of Class 3 with other injectable local anesthetics. Appropriateness of Use. Substances that clearly are intended for use in equine therapeutics are placed in lower classes. Substances that clearly are not intended for use in the horse are placed in higher classes, particularly if they might affect the outcome of a race. Substances that are recognized as legitimately useful in equine therapeutics but could affect the outcome of a race are placed in the middle or higher classes.
Class 1 substances have the highest pharmacologic potential to affect performance
and have no generally accepted medical use in racing greyhounds.
Opiates and opium derivatives, synthetic opioids, psychoactive drugs in DEA Schedules I and II, including: Greyhound Medication Classification and Penalty Guidelines Carfentanil Cocaine Codeine Etorphine Fentanil Hydromorphone Levorphanol Methadone Morphine Oxycodone Oxymorphone PCP Sufentanil Methaqualone Amphetamines or amphetamine-like drugs in DEA Schedules I and II, including: Amphetamine Methamphetamine Methylphenidate Class 2 Class 2 substances are prominent central nervous system stimulants in the lesser DEA Schedules. Opiates and opium derivatives with accepted medical use but not listed solely as Schedule I or II drugs, including: Buprenorphine Meperidine Nalophine Pentazocine Racemorphan Racemethorphan Valium Chloral hydrate Droperidol Meprobromate Methohexital Stimulants in lesser DEA schedules, including: Benzphetamine Diethylproprion Mazindol Pemoline Class 3 Class 3 substances are non-scheduled drugs that have no generally accepted therapeutic use in racing greyhounds, drugs that could alter performance in a normal, healthy untreated racing greyhound, drugs that have a high potential for Greyhound Medication Classification and Penalty Guidelines abuse as local anesthetics, and potent diuretics with potential for diluting a urine specimen. Non-scheduled opiates including: Narcotic analgesics in lesser DEA schedules, including: Local anesthetics with high potential for abuse as nerve-blocking agents, including: Sympathomimetics and other central nervous system stimulants unlikely to be picked up through the food chain, including: Aminophylline Dopram Ephedrine Metaraminol Phenylpropanolamine Theophylline Wyamine sulfate Non-scheduled central nervous system depressants and tranquilizers including: Acepromazine Azaparone Chlorpromazine Detomidine Fluphenazine Ketamine Promazine Propiopromazine Reserpine Diuretics likely to significantly dilute a urine specimen including: Class 4 Class 4 substances are non-scheduled drugs with cardiac or respiratory effects, mild sedatives, steroidal anti-inflammatory drugs with short withdrawal times indicating race day administration. Autonomic nervous system drugs with primarily cardiac or respiratory systems, including: Greyhound Medication Classification and Penalty Guidelines Atropine Epinephrine Metaproteranol Norepinephrine Phenoxybenzamine Phenylphrine Propranolol Terbutaline Local anesthetics with less potential for use as nerve blocking agents, including: Antihistamines with mild sedative properties, including: Corticosteroids with short withdrawal times indicating race day administration, including: Betamethasone Dexamethasone Prednisolone Sympathomimetics and other central nervous system stimulants with some likelihood of appearing through the food chain, including: Depressants with some likelihood of appearing through the food chain, including: Class 5 Class 5 substances are therapeutic medications routinely used to restore the health of an ailing greyhound. Anti-inflammatory drugs, including: Salicylate Phenylbutazone Flunixin Ibuprofen Naproxen Tiaprofenic acid Zomepriac Feldene Dipyrone Mild diuretics not traditionally used as diluting agents which are likely to be found in combination with other medication in an anti-inflammatory product, including: Greyhound Medication Classification and Penalty Guidelines Autonomic nervous system drugs without central nervous system, cardiac, or respiratory effects, including: Bethanecol Ergonovine Ergotamine Glycopyrrolate Propantheline Antihistamines without central nervous system depressant effects, including: Chlorpheniramine Cimetidine Pyrilamine Tripelannamine Dantrolene Guaifenasin Methocarbamol Nefopam Orphenadine Peroxide scavengers or mild anti-inlammatory carry agents, including: Cardiac glycosides or antiarrhythmics, including: Digoxin Procainamide Quinidine Verapamill Class 6 Class 6 substances are local anesthetics likely to produce urinary levels due to factors other than use as a nerve blocking agent, including: Substances are likely to interfere with testing procedures, including: Sulfa drugs Polyethylene glycol Mebendazole Fenbendazole Greyhound Medication Classification and Penalty Guidelines Penalty Determinations
When determining the amount of a penalty, the judges should consider what penalty
would best punish the violator for the harm caused by the violation and deter future
similar violations by the violator and other licensees.
The judges should avoid blindly assessing "consistent" penalties without regard to the specifics of each case. Each violation must be reviewed according to the individual circumstances of the case. The Legislature intended each Board of Judges to use the qualifications, experience, and collective wisdom of its members to act as an adjudicatory body when considering violations of the Act or the Rules. To ensure due process for the affected licensees, every violation must be judged on the evidence presented to the judges, with the judges weighing the evidence and the credibility of the witnesses. Mitigating/Aggravating Circumstances
Because the facts of each case will vary, an exhaustive list of mitigating or
aggravating circumstances is not practical. Generally, mitigating or aggravating
circumstances must be shown by persuasive, credible evidence that the
circumstances were actually present in the instant case, not mere speculation that
the circumstances could have been present. An example of mitigating
circumstances is when the trainer presents credible evidence that another individual
actually caused the greyhound to race with a prohibited substance in its system. An
example of aggravating circumstances is when the staff or other party to the
proceeding presents credible evidence that the trainer administered a prohibited
substance or permitted a prohibited substance to be administered despite warnings
that the administration of the substance would likely result in a positive test.
The amount of the substance in a sample should not be considered a mitigating or
aggravating factor. The definition of a prohibited substance adopted by the
Commission in §319.1(b) establishes a zero-tolerance standard. In other words, the
presence in a post-race sample of any amount of a prohibited drug, chemical, or
other substance is a per se violation of the Commission's rules.
The following recommended penalties should be followed in all cases in the absence
of persuasive, credible evidence of mitigating circumstances justifying a lesser
penalty or aggravating circumstances justifying an enhanced penalty.
The recommended penalties for medication violations offer a range of penalties,
including fines, suspension, and loss of purse. By offering a range of penalty, it is
the intent of the Commission that for a first violation involving a particular substance,
the penalty would be at the lower end of the range, absent mitigating or aggravating
circumstances. Conversely, for a subsequent violation for a particular substance,
the penalty would be at the higher end of the range. The penalty should be
enhanced for subsequent violations regardless of when the subsequent violations
occur with respect to the first violation. Because a licensee's compliance history with
respect to a particular substance is incorporated into the recommended penalties,
Greyhound Medication Classification and Penalty Guidelines the licensee's overall compliance history should not be considered a mitigating circumstance. In all cases, however, the judges have the discretion to impose the penalty that best accomplishes the Commission's enforcement goals: 1. To protect the health and safety of the participants in racing, including 2. To ensure pari-mutuel racing is conducted honestly and fairly. Violations involving positive tests Class 1 substance: 1 year suspension, $5,000 fine, and loss of purse 6 months - 1 year suspension and $2,500-$5,000 fine, and loss of purse 30-180 days suspension and $750-$2,500 fine, and loss of purse 5-30 days suspension and $200-$750 fine, and loss of purse Violations involving contraband Unauthorized possession of substance in Class 1, 2, or 3: 1/2 the recommended penalty for medication violation for the applicable class of substance Unauthorized possession of substance in other class found in a location indicating high probability of intended use on association grounds (i.e. kennel, loaded syringe): 1/2 the recommended penalty above for the applicable class of substance Unauthorized possession of substance in other class found in a location indicating low probability of intended use on association grounds (i.e. inadvertently left in vehicle when entering kennel area): Written warning or fine at discretion of racing judges Unauthorized possession of controlled substance not included in classification primarily used by humans: Fine or suspension at discretion of racing judges Greyhound Medication Classification and Penalty Guidelines Possession of a weapon prohibited under Penal Code §46.05: Possession of other weapons or ammunition: Possession of unloaded syringe with needle capable of giving injections: Possession of syringe loaded with prohibited substance: 1/2 the recommended penalty for medication violation for the applicable class of substance Possession of alcoholic beverages in restricted area: Oral or written warning or fine at discretion of racing judges Greyhound Medication Classification and Penalty Guidelines
ﬁle:///The Cas e Agains t Nuclear PowerTHE CASE AGAINST NUCLEAR POWERGORDON TAYLOR2011-06-06The critical issue for nuclear power is the consequences of a major radioactive release. These were predicted in theSandia CRAC-2 study as 42,000 to 100,000 early deaths. They were confirmed empirically by Chernobyl, whichcontaminated huge areas of the Ukraine, Belarus and Russia as well as 40% of Europ